Titanium implants possessing excellent antibacterial activity are highly desirable for the prevention of implant-associated infections. In this study, we demonstrate a simple one-step, water-based procedure for the fabrication of biofunctionalized nanocomposites on titanium for implant application. The formation of biofunctionalized silver nanoparticles with varied biomolecule templates is confirmed by Fourier-transform infrared spectroscopic, contact angle, field-emission scanning electron microscopy, and inductively coupled plasma atomic emission spectrometry analysis. Antibacterial properties of the specimens were determined by challenging them against Staphylococcus aureus. The Ag-incorporated titanium shows excellent antibacterial ability against planktonic bacteria in the suspension and ability to prevent bacterial adhesion. The specimens with optimized biomolecule/silver ratio promote osteoblast differentiation. These biofunctionalized silver nanoparticles-doped titanium specimens, with improved antibacterial activity while maintaining healthy osteoblast cellular activity, have promising application in orthopedics, dentistry, and other biomedical devices.
AnituaEPradoROriveG. Effects of calcium-modified titanium implant surfaces on platelet activation, clot formation, and osseointegration. J Biomed Mater Res A2015; 103: 969–980.
2.
SongWZhaoLFangK. Biofunctionalization of titanium implant with chitosan/sirna complex through loading-controllable and time-saving cathodic electrodeposition. J Mater Chem B2015; 3: 8567–8576.
3.
LinDTsaiMShiehT. In vitro antibacterial activity and cytocompatibility of bismuth doped micro-arc oxidized titanium. J Biomater Appl2013; 27: 553–563.
4.
PetersonAMMoühwaldHShchukinDG. pH-controlled release of proteins from polyelectrolyte-modified anodized titanium surfaces for implant applications. Biomacromolecules2012; 13: 3120–3126.
5.
GristinaAG. Implant failure and the immuno-incompetent fibro-inflammatory zone. Clin Orthop Relat Res1994; 298: 106–118.
6.
HardesJAhrensHGebertC. Lack of toxicological side-effects in silver-coated megaprostheses in humans. Biomaterials2007; 28: 2869–2875.
7.
SchmalzriedTPAmstutzHCAuMK. Etiology of deep sepsis in total hip arthrosplasty the significance of hematogenous and recurrent infections. Clin Orthop Rel Res1992; 280: 200–207.
8.
DarouicheRO. Device-associated infections: a macroproblem that starts with microadherence. Clin Infect Dis2001; 33: 1567–1572.
9.
DarouicheRO. Treatment of infections associated with surgical implants. N Engl J Med2004; 350: 1422–1429.
10.
DarwicheHBarsoumWKKlikaA. Retrospective analysis of infection rate after early reoperation in total hip arthroplasty. Clin Orthop Relat Res2010; 468: 2392−2396–2392−2396.
11.
JafariSMCoyleCMortazaviSMJ. Revision hip arthroplasty: infection is the most common cause of failure. Clin Orthop Relat Res2010; 468: 2046−2051–2046−2051.
12.
GasikMMellaertLVPierronD. Reduction of biofilm infection risks and promotion of osteointegration for optimized surfaces of titanium implants. Adv Healthc Mater2012; 1: 117–127.
13.
WangXChengFGaoJ. Antibacterial wound dressing from chitosan/polyethylene oxide nanofibers mats embedded with silver nanoparticles. J Biomater Appl2015; 29: 1086–1095.
EckhardtSBrunettoPSGagnonJ. Nanobio silver: its interactions with peptides and bacteria, and its uses in medicine. Chem Rev2013; 113: 4708−4754–4708−4754.
16.
SongWHRyuHSHongSH. Antibacterial properties of Ag (or Pt)-containing calcium phosphate coatings formed by micro-arc oxidation. J Biomed Mater Res2009; 88 A: 246−254–246−254.
17.
SidrimJJCTeixeiraCECCordeiroRA. β-lactam antibiotics and vancomycin inhibit the growth of planktonic and biofilm Candida spp.: an additional benefit of antibiotic-lock therapy?Int J Antimicrob Ag2015; 45: 420–423.
18.
PavlukhinaSLuYPatimethaA. Polymer multilayers with pH-triggered release of antibacterial agents. Biomacromolecules2010; 11: 3448–3456.
AvilaEDLimaBPSekiyaT. Effect of UV-photofunctionalization on oral bacterial attachment and biofilm formation to titanium implant material. Biomaterials2015; 67: 84–92.
21.
ZhaoLChuPZhangY. Antibacterial coatings on titanium implants. J Biomed Mater Res B2009; 91: 470–480.
22.
MahTFO’TooleGA. Mechanisms of biofilm resistance to antimicrobial agents. Trends Microbiol2001; 9: 34–39.
23.
RoyMFieldingGABeyenalH. Mechanical, in vitro antimicrobial, and biological properties of plasma-sprayed silver-doped hydroxyapatite coating. ACS Appl Mater Interfaces2012; 4: 1341–1349.
24.
NeculaBSFratila-ApachiteiLEZaatSA. In vitro antibacterial activity of porous Tio2-Ag composite layers against methicillin resistant Staphylococcus aureus. Acta Biomater2009; 5: 3573–3580.
25.
AgarwalAWeisTLSchurrMJ. Surfaces modified with nanometer-thick silver-impregnated polymeric films that kill bacteria but support growth of mammalian cells. Biomaterials2010; 31: 680–690.
26.
ChenMZhaoYYangW. UV-irradiation-induced templated/in-situ formation of ultrafine silver/polymer hybrid nanoparticles as antibacterial. Langmuir2013; 29: 16018−16024–16018−16024.
27.
RamstedtMEkstrand-HammarstromBShchukarevAV. Bacterial and mammalian cell response to poly(3-sulfopropyl methacrylate) brushes loaded with silver halide salts. Biomaterials2009; 30: 1524–1531.
28.
RoyMBandyopadhyayABoseS. In vitro antimicrobial and biological properties of laser assisted tricalcium phosphate coating on titanium for load bearing implant. Mat Sci Eng C Mater2009; 29: 1965–1968.
29.
DasKBoseSBandyopadhyayA. Surface coatings for improvement of bone cell materials and antimicrobial activities of Ti implants. J Biomed Mater Res B2008; 87: 455−460–455−460.
30.
KämmererPWHellerMBriegerJ. Biofunctionalization strategies on tantalum-based materials for osseointegrative applications. Eur Cells Mater2011; 21: 364–372.
31.
KimSESongSHYunYP. The effect of immobilization of heparin and bone morphogenic protein-2 (BMP-2) to titanium surfaces on inflammation and osteoblast function. Biomaterials2011; 32: 366–373.
32.
PetersonAMPilz-AllenCKolesnikovaT. Growth factor release from polyelectrolyte-coated titanium for implant applications. ACS Appl Mater Interfaces2014; 6: 1866–1871.
33.
CarterDCHeXMunsonSH. Three-dimensional structure of human serum albumin. Science1989; 244: 1195–1198.
34.
HuangSZhuFQianQ. Thermodynamic investigation of interaction between [(η6-p-cymene) RuII(acetone-N4-phenylthiosemicarbazone)Cl]Cl anticancer drug and human serum albumin: spectroscopic and electrochemical studies. Biol Trace Elem Res2015; 164: 150–161.
35.
MathewJPJosephPThomasVC. Glutathione and associated enzymes in toxic cataractogenesis-selenite model. J Environ Biol2006; 27: 733–738.
36.
WuGFangYYangS. Glutathione metabolism and its implications for health. J Nutr2004; 134: 489–492.
37.
HuoKZhangXWangH. Osteogenic activity and antibacterial effects on titanium surfaces modified with Zn-incorporated nanotube arrays. Biomaterials2013; 34: 3467–3478.
38.
YangLXingRShenQ. Fabrication of protein-conjugated silver sulfide nanorods in the bovine serum albumin solution. J Phys Chem B2006; 110: 10534–10539.
39.
BauerSSchmukiPvon der MarkK. Engineering biocompatible implant surfaces Part I: materials and surfaces. Prog Mater Sci2013; 58: 261–326.
40.
Mas-MorunoCGarridoBRodriguezD. Biofunctionalization strategies on tantalum-based materials for osseointegrative applications. J Mater Sci Mater Med2015; 26: 109–109.
41.
GottenbosBvan der MeiHCBusscherHJ. Initial adhesion and surface growth of Staphylococcus epidermidis and Pseudomonas aeruginosa on biomedical polymers. J Biomed Mater Res2000; 50: 208–214.
42.
ColonGWardBCWebsterTJ. Increased osteoblast and decreased Staphylococcus epidermidis functions on nanophase ZnO and TiO2. J Biomed Mater Res A2006; 78: 595–604.
43.
MorraM. Biochemical modification of titanium surfaces: peptides and Ecm proteins. Eur Cell Mater2006; 12: 1–15.
44.
CampocciaDMontanaroLArciolaCR. The significance of infection related to orthopedic devices and issues of antibiotic resistance. Biomaterials2006; 27: 2331–2339.
45.
MatsumuraYYoshikataKKunisakiS. Mode of bactericidal action of silver zeolite and its comparison with that of silver nitrate. Appl Environ Microbiol2003; 69: 4278–4281.
46.
FengQLWuJChenGQ. A mechanistic study of the antibacterial effect of silver ions on Escherichia coli and Staphylococcus aureus. J Biomed Mater Res2000; 52: 662–668.
47.
ChenWLiuYCourtneyHS. In vitro anti-bacterial and biological properties of magnetron co-sputtered silver-containing hydroxyapatite coating. Biomaterials2006; 27: 5512−5517–5512−5517.
48.
DibrovPDziobaJGosinkKK. Chemiosmotic mechanism of antimicrobial activity of Ag+ in Vibrio cholerae. Antimicrob Agents Chemother2002; 46: 2668–2670.
JungWKKooHCKimKW. Antibacterial activity and mechanism of action of the silver ion in Staphylococcus aureus and Escherichia coli. Appl Environ Microbiol2008; 74: 2171–2178.
51.
LordMSFossMBesenbacherF. Influence of nanoscale surface topography on protein adsorption and cellular response. Nano Today2010; 5: 66–78.
